Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
WW
WW
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
WW News
Weight Watchers Partners with PVOLVE for Enhanced Weight Health Solutions
5d ago
Newsfilter
Valaris Shares Surge 21.8% Amid Transocean Acquisition Deal
6d ago
Benzinga
Amazon Enters GLP-1 Drug Market, Competing with Pharma Giants
Feb 06 2026
Fool
Novo Nordisk's Oral Wegovy Hits Record 20,371 Prescriptions in Second Week, Nearly 500% Surge
Jan 23 2026
Benzinga
Amazon Launches Novo Nordisk's Wegovy Weight-Loss Pill with Monthly Costs Starting at $25
Jan 09 2026
Newsfilter
Novo Nordisk Launches Wegovy Pill with 17% Average Weight Loss Efficacy
Jan 05 2026
Benzinga
Novo Nordisk Launches First GLP-1 Weight Loss Pill in the U.S. Starting at $149/Month
Jan 05 2026
CNBC
Weight Watchers Launches Wegovy Oral Medication at $149 Monthly Fee
Jan 05 2026
Globenewswire
Weight Watchers Launches Wegovy Oral Medication at $149 Monthly Fee
Jan 05 2026
Newsfilter
Novo Nordisk Launches First GLP-1 Weight Loss Pill at $149 Monthly
Jan 05 2026
Newsfilter
Novo Nordisk and Eli Lilly Launch Weight-Loss Drugs Targeting $150 Billion Market
Dec 29 2025
Newsfilter
Novo Nordisk Receives FDA Approval for Wegovy, Shares Surge 8.6%
Dec 23 2025
Benzinga
Cementos Pacasmayo, Rezolve AI, Emerald Holding, and Other Major Stocks Rising on Monday
Dec 16 2025
Benzinga
Weight Watchers Launches GLP-1 Success Program to Enhance Weight Loss Support
Dec 16 2025
Globenewswire
Weight Watchers Launches GLP-1 Success Program to Enhance Weight Loss Support
Dec 16 2025
Globenewswire
Weight Watchers Launches GLP-1 Support Platform to Enhance Weight Loss for Users
Dec 16 2025
Globenewswire
Show More News
